Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitesunpharma.com
Twitter@SunPharma_IR
CategoryBioTech
Employees

Offices

Mumbai, IND
Acme Plaza
Andheri - Kurla Rd, Andheri (E)
Mumbai, 400 059, IND

People

Formulation Scientist

Acquisitions

Total$3.2B
Ranbaxy Laboratories, 4/2014 $3.2B
DUSA Pharmaceuticals, 11/2012

Tags

Sun Pharma

Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms.

Recent Milestones

Videos

Screenshots

Sun Pharma screenshot
Above: Sun Pharma
Uploaded: 11/9/12

Sources

  1. Sun Pharma to buy Ranbaxy in $3.2 bn deal Read more at: http://economictimes.indiatimes.com/articleshow/33365818.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst (economictimes.indiatimes.com) [edit]
  2. Sun Pharma to Acquire DUSA Pharmaceuticals, Inc. (in.finance.yahoo.com) [edit]
  3. Indian drugs group eyes $5b Swedish pharma takeover (bbc.co.uk) [edit]
    Indian drugs group eyes $5b Swedish pharma takeover (bbc.co.uk) [edit]
    India's Sun Pharmaceuticals Readies $5 Billion Deal for Sweden's Meda (online.wsj.com) [edit]
    Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal (profit.ndtv.com) [edit]
Edit This Page
Last Edited 4/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy